StockClub

ADMA

ADMAADMA Biologics, Inc.$ --
ADMA Biologics, Inc.

ADMA Biologics, Inc.

ADMA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
139M USD
YoY +18.4%
Operating Income
63M USD
YoY +63.7%
Net Income
49M USD
YoY -55.9%
EPS
0.21$
YoY -55.3%

Revenue

$510.2M
FY2024 Q1$81.9M
$81.9M
Q1
FY2024 Q2$189.1M
$189.1M
Q2
FY2024 Q3$308.9M
$308.9M
Q3
FY2024 Q4$426.5M
$426.5M
Q4
FY2025 Q1$114.8M
$114.8M
Q1
FY2025 Q2$236.8M
$236.8M
Q2
FY2025 Q3$371M
$371M
Q3
FY2025 Q4$510.2M
$510.2M
Q4
Actual
+$83.7M (+19.6%)

Net Income

$146.9M
FY2024 Q1$17.8M
$17.8M
Q1
FY2024 Q2$49.9M
$49.9M
Q2
FY2024 Q3$85.8M
$85.8M
Q3
FY2024 Q4$197.7M
$197.7M
Q4
FY2025 Q1$26.9M
$26.9M
Q1
FY2025 Q2$61.1M
$61.1M
Q2
FY2025 Q3$97.6M
$97.6M
Q3
FY2025 Q4$146.9M
$146.9M
Q4
Actual
$-50.7M (-25.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$42.2M
Est:$41.1M
FY2020BEAT
$42.2M
FY2021BEAT
Actual:$80.9M
Est:$76.2M
FY2021BEAT
$80.9M
FY2022BEAT
Actual:$154.1M
Est:$151.5M
FY2022BEAT
$154.1M
FY2023MISS
Actual:$258.2M
Est:$330.2M
FY2023MISS
$258.2M
FY2024BEAT
Actual:$426.5M
Est:$421.7M
FY2024BEAT
$426.5M
FY2025MISS
Actual:$510.2M
Est:$510.6M
FY2025MISS
$510.2M

Analyst Estimates